Rationale and study design of the neurocardiac therapy for heart failure study: NECTAR-HF

European Journal of Heart Failure

Volumn 16, Issue 6, 2014, Pages 692-699

  De Ferrari, Gaetano M ^a   Tuinenburg, Anton E ^b   Ruble, Stephen ^c   Brugada, Josep ^d   Klein, Helmut ^e   Butter, Christian ^f,g   Wright, David J ^h   Schubert, Bernd ^h   Solomon, Scott ^c   Meyer, Scott ^c   Stein, Kenneth ^c   Ramuzat, Agnes ^h   Zannad, Faiez ⁱ  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c BOSTON SCIENTIFIC CORPORATION   (United States)

^d HOSPITAL CLÍNIC   (Spain)

^e OTTO VON GUERICKE UNIVERSITY   (Germany)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g Brandenburg Klinik   (Germany)

^h Department of Cardiology Liverpool Heart and Chest ^*  (Belgium)

ⁱ UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Autonomic; Cardiac; Device; Heart; Parasympathetic; Vagal

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ATRIAL NATRIURETIC FACTOR; C REACTIVE PROTEIN; CASPASE 3; ENDOTHELIN; FAS LIGAND; GELATINASE B; INTERLEUKIN 6; PROADRENOMEDULLIN; PYRIDINOLINE; RYANODINE RECEPTOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ADHESION PROTEIN 1; VASOACTIVE INTESTINAL POLYPEPTIDE; BIOLOGICAL MARKER;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CARDIOPULMONARY EXERCISE TEST; CONTROLLED STUDY; DEVICE SAFETY; DISEASE COURSE; ECHOCARDIOGRAPHY; EXERCISE; FOLLOW UP; FUNCTIONAL STATUS; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTABLE PULSE GENERATOR; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; NERVE STIMULATOR; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STUDY DESIGN; VAGUS NERVE STIMULATION; CLINICAL TRIAL; EXERCISE TEST; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; METHODOLOGY; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

BIOMARKERS; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; EXERCISE TEST; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; QUALITY OF LIFE; RESEARCH DESIGN; STROKE VOLUME; TREATMENT OUTCOME; VAGUS NERVE STIMULATION; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84899417492     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.80     Document Type: Article

References (26)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB,. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013; 127: e6-e245.
2. Yancy CW,. Comprehensive treatment of heart failure: state-of-the-art medical therapy. Rev Cardiovasc Med 2005; 6 (Suppl 2): S43-S57. (Pubitemid 40704096)
3. Mortara A, La Rovere MT, Pinna GD, Prpa A, Maestri R, Febo O, Pozzoli M, Opasich C, Tavazzi L,. Arterial baroreflex modulation of heart rate in chronic heart failure. Clinical and hemodynamic correlates and prognostic implications. Circulation 1997; 96: 3450-3458. (Pubitemid 27513419)
4. Ponikowski P, Anker SD, Chua TP, Szelemej R, Piepoli M, Adamopoulos S, Webb-Peploe K, Harrington D, Banasiak W, Wrabec K, Coats AJ,. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997; 79: 1645-1650. (Pubitemid 27339475)
5. Schwartz PJ, De Ferrari GM, Sanzo A, Landolina M, Rordorf R, Raineri C, Campana C, Revera M, Ajmone-Marsan N, Tavazzi L, Odero A,. Long term vagal stimulation in patients with advanced heart failure: first experience in man. Eur J Heart Fail 2008; 10: 884-891.
6. De Ferrari GM, Crijns HJ, Borggrefe M, Milasinovic G, Smid J, Zabel M, Gavazzi A, Sanzo A, Dennert R, Kuschyk J, Raspopovic S, Klein H, Swedberg K, Schwartz PJ,. CardioFit Multicenter Trial Investigators. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J 2011; 32: 847-855.
7. Hamann JJ, Ruble SB, Stolen C, Wang M, Gupta RC, Rastogi S, Sabbah HN,. Vagus nerve stimulation improves left ventricular function in a canine model of chronic heart failure. Eur J Heart Fail 2013; 15: 1319-1326.
8. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM,. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
9. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K,. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 2004; 109: 120-124. (Pubitemid 38056032)
10. Zhang Y, Popovic ZB, Bibevski S, Fakhry I, Sica DA, Van Wagoner DR, Mazgalev TN,. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail 2009; 2: 692-699.
11. Sabbah HN, Stein PD, Kono T, Gheorghiade M, Levine TB, Jafri S, Hawkins ET, Goldstein S,. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol 1991; 260: H1379-H1384.
12. Sabbah HN, Ilsar I, Zaretsky A, Rastogi S, Wang M, Gupta RC,. Vagus nerve stimulation in experimental heart failure. Heart Fail Rev 2011; 16: 171-178.
13. De Ferrari GM, Schwartz PJ,. Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. Heart Fail Rev 2011; 16: 195-203.
14. Tracey KJ,. The inflammatory reflex. Nature 2002; 420: 853-859. (Pubitemid 36019638)
15. Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ,. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 1991; 68: 1471-1481.
16. De Ferrari GM, Vanoli E, Schwartz PJ,. Vagal activity and ventricular fibrillation. In: Vagal Control of the Heart: Experimental Basis and Clinical Implications (, Levy MN, and, Schwartz PJ, eds). Futura Publishing Co, Armonk, NY, 1994; 613-636.
17. Cohn JN, Ferrari R, Sharpe N,. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 2000; 35: 569-582. (Pubitemid 30167013)
18. Kramer DG, Trikalinos TA, Kent DM, Antonopoulos GV, Konstam MA, Udelson JE,. Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach. J Am Coll Cardiol 2010; 56: 392-406.
19. Abraham WT, Young JB, Leon AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR,. Multicenter In Sync ICD II Study Group. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004; 110: 2864-2868. (Pubitemid 39473610)
20. St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, Loh E, Kocovic DZ, Fisher WG, Ellestad M, Messenger J, Kruger K, Hilpisch KE, Hill MR,. Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003; 107: 1985-1990. (Pubitemid 36506071)
21. Freeman TB, Vawter DE, Leaverton PE, Godbold JH, Hauser RA, Goetz CG, Olanow CW,. Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. N Engl J Med 1999; 341: 988-992. (Pubitemid 29441556)
22. Macklin R,. The ethical problems with sham surgery in clinical research. N Engl J Med 1999; 341: 992-996. (Pubitemid 29441557)
23. Hauptman PJ, Schwartz PJ, Gold MR, Borggrefe M, Van Veldhuisen DJ, Starling RC, Mann DL,. Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HF. Am Heart J 2012; 163: 954-962.e1.
24. Anholt TA, Ayal S, Goldberg JA,. Recruitment and blocking properties of the CardioFit stimulation lead. J Neural Eng 2011; 8: 034004. doi: 10.1088/1741-2560/8/3/034004.
25. Yoo PB, Lubock NB, Hincapie JG, Ruble SB, Hamann JJ, Grill WM (2013) High-resolution measurement of electrically-evoked vagus nerve activity in the anesthetized dog. J Neural Eng 2013; 10: 026003. doi: 10.1088/1741-2560/10/2/ 026003.
26. DiCarlo L, Libbus I, Amurthur B, Kenknight BH, Anand IS,. Autonomic Regulation Therapy for the Improvement of Left Ventricular Function and Heart Failure Symptoms: The ANTHEM-HF Study. J Card Fail 2013; 19: 655-660.